The FDA Has Already Authorized Clinical Trials Into the Therapeutic Potential of MDMA for Patients With PTSD, But Now it’s Given the Green Light to a Psychedelics Research Institute to Expand its Studies By Administering the Substance to Certain Therapists
Volunteer therapists who are being trained to treat people with PTSD will be able to participate in the Phase 1 trials to gain personal experience with the treatment option. This is a complementary research project that comes as the Multidisciplinary Association for Psychedelic Studies (MAPS) is in the process of conducting Phase 3 trials involving people with the disorder.
Super League: Fragen und Antworten zum Erdbeben im europäischen Klub-Fußball spox.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spox.com Daily Mail and Mail on Sunday newspapers.
Pre-CES Presentation Looks at the Winners and Losers of Tech in 2020
Not every company was impacted by the coronavirus in the same way.
The pandemic year of 2020 was a good year for TVs and PCs, as well as surprising products like webcams, monitors and PC headsets, although the news was less positive for headphones and the smartphones.
That’s according to Stephen Baker of the research firm NPD Group, who delivered a presentation Wednesday as part of a virtual media event held ahead of next week’s virtual International CES, and hosted by conference host Techfluence.
In the presentation, titled “Right Place, Right Product, Right Time, The Go-To Consumer Technology Products For the Pandemic,” Baker shared several trends in tech from 2020, and discussed whether they will continue in a post-pandemic world.